Last update:

Overweight & Obesity news

Health

Ozempic Meals? Restaurants shrink portions to match bite-sized hunger

A self-described foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has long loved exploring the city's famed restaurant culture.

Medications

Novo Nordisk says US approves first GLP-1 pill for weight loss

Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight loss.

Overweight & Obesity

Ret finger protein: A hidden molecular switch that fuels obesity

Obesity is one of the greatest burdens of global public health. One major factor that drives obesity is excessive fat accumulation. Despite decades of research, the biological processes that trigger this abnormal fat accumulation ...

Overweight & Obesity

States retreat from covering drugs for weight loss

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for the cuts included in President Donald Trump's broad tax and spending law.

Psychology & Psychiatry

One short quiz could help people stick to their weight loss plans

A new study, published in JMIR Formative Research, has found that people who answered a brief quiz to determine their "eating profile" were more likely to stick with their program and stay committed to their weight loss goals ...

Overweight & Obesity

COVID-19 pandemic linked to increases in childhood obesity

The COVID-19 pandemic not only disrupted children's education, recreation, and social lives, but it also increased the prevalence of obesity in the U.S. pediatric population by roughly 1 million youngsters, according to a ...

Alzheimer's disease & dementia

Blood test shows obesity speeds Alzheimer's development

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in non-obese individuals, ...

Overweight & Obesity

WHO backs GLP-1 treatments to tackle obesity epidemic

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which affects over one billion people worldwide, the World Health Organization said Monday.

Medications

WHO recommends Ozempic-style weight loss drugs for obesity

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic burden.

Health

Study links America's favorite cooking oil to obesity

Soybean oil, the most widely consumed cooking oil in the United States and a staple of processed foods, contributes to obesity, at least in mice, through a mechanism scientists are now beginning to understand.

Neuroscience

Study finds brain enzyme inhibition reduces obesity in mice

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers at Université de Montréal's affiliated hospital research center ...

Surgery

Research uncovers key bariatric surgery complication cause

Postprandial hypoglycemia is one of the main complications of bariatric surgery and can affect up to 30% of patients. Unlike ordinary hypoglycemia, in which low blood sugar is usually associated with little food, postprandial ...

Overweight & Obesity

Study links metal levels in urine to childhood obesity risk

Researchers from the Granada Biosanitary Research Institute and the University of Granada have revealed positive and negative associations between exposure to a combination of different metals and overweight and obesity in ...

Overweight & Obesity

Are weight loss drugs like Ozempic, Wegovy safe for kids?

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional—and often ineffective—advice to "eat less and exercise more."

Health

Weight loss brings Americans big health care savings

The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private insurers.

Overweight & Obesity

Paternal weight associated with baby's size at birth, study finds

A study in Brazil involving 89 father-mother-baby triads points to an association between paternal overweight and newborn birth weight: the higher the father's body mass index (BMI, weight divided by height squared), the ...

Overweight & Obesity

Why some people don't lose weight with Wegovy

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don't work for everyone.